Germline mutations in genes encoding several components of the retinoblasto
ma pathway have been linked with inherited predisposition to melanoma, Most
commonly, such mutations involve CDKN2A, a cyclin-dependant kinase inhibit
or of two kinases, CDK4 and CDK6, which phosphorylate the retinoblastoma pr
otein (pRB) and thereby promote passage through the G(1)/S cell-cycle restr
iction point. Less frequently, germline mutations in the CDK4 gene have als
o been linked with an increased risk of melanoma, Despite the sequence and
functional homology between CDK4 and CDK6, the role of germline mutations i
n CDK6 in melanoma predisposition is unknown. We detected no CDK6 mutations
within the p16 (CDKN2A) binding domain in index cases from 60 melanoma-pro
ne kindreds that lacked germline mutations in the coding regions of either
CDKN2A or within the entire CDK4 coding region. We conclude that germline m
utations in CDK6 do not make a significant contribution to melanoma predisp
osition.